BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 34906067)

  • 1. OTC intron 4 variations mediate pathogenic splicing patterns caused by the c.386G>A mutation in humans and spf
    Sacchetto C; Peretto L; Baralle F; Maestri I; Tassi F; Bernardi F; van de Graaf SFJ; Pagani F; Pinotti M; Balestra D
    Mol Med; 2021 Dec; 27(1):157. PubMed ID: 34906067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An Exon-Specific Small Nuclear U1 RNA (ExSpeU1) Improves Hepatic OTC Expression in a Splicing-Defective
    Balestra D; Ferrarese M; Lombardi S; Ziliotto N; Branchini A; Petersen N; Bosma P; Pinotti M; van de Graaf SFJ
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33228018
    [No Abstract]   [Full Text] [Related]  

  • 3. Functional characterization of the spf/ash splicing variation in OTC deficiency of mice and man.
    Rivera-Barahona A; Sánchez-Alcudia R; Viecelli HM; Rüfenacht V; Pérez B; Ugarte M; Häberle J; Thöny B; Desviat LR
    PLoS One; 2015; 10(4):e0122966. PubMed ID: 25853564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An Altered Splicing Registry Explains the Differential ExSpeU1-Mediated Rescue of Splicing Mutations Causing Haemophilia A.
    Balestra D; Maestri I; Branchini A; Ferrarese M; Bernardi F; Pinotti M
    Front Genet; 2019; 10():974. PubMed ID: 31649737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of a strong F9 cryptic 5'ss by intrinsic elements and by combination of tailored U1snRNAs with antisense oligonucleotides.
    Balestra D; Barbon E; Scalet D; Cavallari N; Perrone D; Zanibellato S; Bernardi F; Pinotti M
    Hum Mol Genet; 2015 Sep; 24(17):4809-16. PubMed ID: 26063760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Compensatory U1snRNA Partially Rescues FAH Splicing and Protein Expression in a Splicing-Defective Mouse Model of Tyrosinemia Type I.
    Balestra D; Scalet D; Ferrarese M; Lombardi S; Ziliotto N; C Croes C; Petersen N; Bosma P; Riccardi F; Pagani F; Pinotti M; van de Graaf SFJ
    Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32244944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disease-causing variants of the conserved +2T of 5' splice sites can be rescued by engineered U1snRNAs.
    Scalet D; Maestri I; Branchini A; Bernardi F; Pinotti M; Balestra D
    Hum Mutat; 2019 Jan; 40(1):48-52. PubMed ID: 30408273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-throughput analysis revealed mutations' diverging effects on
    Souček P; Réblová K; Kramárek M; Radová L; Grymová T; Hujová P; Kováčová T; Lexa M; Grodecká L; Freiberger T
    RNA Biol; 2019 Oct; 16(10):1364-1376. PubMed ID: 31213135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intronic PAH gene mutations cause a splicing defect by a novel mechanism involving U1snRNP binding downstream of the 5' splice site.
    Martínez-Pizarro A; Dembic M; Pérez B; Andresen BS; Desviat LR
    PLoS Genet; 2018 Apr; 14(4):e1007360. PubMed ID: 29684050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aberrant 5' splice sites in human disease genes: mutation pattern, nucleotide structure and comparison of computational tools that predict their utilization.
    Buratti E; Chivers M; Královicová J; Romano M; Baralle M; Krainer AR; Vorechovsky I
    Nucleic Acids Res; 2007; 35(13):4250-63. PubMed ID: 17576681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutation analysis of the ornithine transcarbamylase (OTC) gene in five Japanese OTC deficiency patients revealed two known and three novel mutations including a deep intronic mutation.
    Ogino W; Takeshima Y; Nishiyama A; Okizuka Y; Yagi M; Tsuneishi S; Saiki K; Kugo M; Matsuo M
    Kobe J Med Sci; 2007; 53(5):229-40. PubMed ID: 18204299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The spfash mouse: a missense mutation in the ornithine transcarbamylase gene also causes aberrant mRNA splicing.
    Hodges PE; Rosenberg LE
    Proc Natl Acad Sci U S A; 1989 Jun; 86(11):4142-6. PubMed ID: 2471197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive characterization of ureagenesis in the spf
    Allegri G; Deplazes S; Rimann N; Causton B; Scherer T; Leff JW; Diez-Fernandez C; Klimovskaia A; Fingerhut R; Krijt J; Kožich V; Nuoffer JM; Grisch-Chan HM; Thöny B; Häberle J
    J Inherit Metab Dis; 2019 Nov; 42(6):1064-1076. PubMed ID: 30714172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of a cryptic 5' splice site reverses the impact of pathogenic splice site mutations in the spinal muscular atrophy gene.
    Singh NN; Del Rio-Malewski JB; Luo D; Ottesen EW; Howell MD; Singh RN
    Nucleic Acids Res; 2017 Dec; 45(21):12214-12240. PubMed ID: 28981879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An exon-specific U1 small nuclear RNA (snRNA) strategy to correct splicing defects.
    Fernandez Alanis E; Pinotti M; Dal Mas A; Balestra D; Cavallari N; Rogalska ME; Bernardi F; Pagani F
    Hum Mol Genet; 2012 Jun; 21(11):2389-98. PubMed ID: 22362925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Informational Suppression to Probe RNA:RNA Interactions in the Context of Ribonucleoproteins: U1 and 5' Splice-Site Base-Pairing.
    Tan J; Roca X
    Methods Mol Biol; 2016; 1421():243-68. PubMed ID: 26965270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. hnRNP H binding at the 5' splice site correlates with the pathological effect of two intronic mutations in the NF-1 and TSHbeta genes.
    Buratti E; Baralle M; De Conti L; Baralle D; Romano M; Ayala YM; Baralle FE
    Nucleic Acids Res; 2004; 32(14):4224-36. PubMed ID: 15299088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploring Splicing-Switching Molecules For Seckel Syndrome Therapy.
    Scalet D; Balestra D; Rohban S; Bovolenta M; Perrone D; Bernardi F; Campaner S; Pinotti M
    Biochim Biophys Acta Mol Basis Dis; 2017 Jan; 1863(1):15-20. PubMed ID: 27639833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prevalent deep intronic c. 639+919 G>A GLA mutation causes pseudoexon activation and Fabry disease by abolishing the binding of hnRNPA1 and hnRNP A2/B1 to a splicing silencer.
    Palhais B; Dembic M; Sabaratnam R; Nielsen KS; Doktor TK; Bruun GH; Andresen BS
    Mol Genet Metab; 2016 Nov; 119(3):258-269. PubMed ID: 27595546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional splicing assay shows a pathogenic intronic mutation in neurofibromatosis type 1 (NF1) due to intronic sequence exonization.
    Raponi M; Upadhyaya M; Baralle D
    Hum Mutat; 2006 Mar; 27(3):294-5. PubMed ID: 16470740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.